The Globe and Mail |
Lung transplant 30 years ago opened a door that saved thousands of lives
The Globe and Mail It’s a reminder just how far medicine has come in a relatively short time, with lung transplants going from the realm of science fiction to comparatively routine procedures (as much as any transplant surgery can be considered routine). The idea of … |
Private MD |
AIDS antibodies fight infection in monkeys
Private MD The results of a new study have shown that AIDS antibodies from humans have been able to strongly suppress the virus in monkeys. This new research may be able to one day alter treatments given to people who tested positive for HIV or AIDS in STD testing. Newly discovered monoclonal antibodies could control HIVVaccine News Daily Theraclone Sciences’ Monoclonal Antibody Candidate PGT121 Suppresses HIV …EON: Enhanced Online News (press release) HIV Cure: New Treatment Discovered Effective Against Infected Cells and HIV …International Business Times AU |
MedCity News |
Keryx’s chronic kidney disease drug shows reduction in serum phosphorus
MedCity News (Reuters) – Keryx Biopharmaceuticals Inc said its kidney drug met the main goals of a mid-stage study in patients with chronic kidney disease who were not on dialysis. Shares of the company rose about 16 percent to $12.84 in premarket trading. The drug … Keryx says kidney drug effective; shares hit seven-year highReuters India Keryx Says Kidney Disease Drug Zerenex WorkedDrug Discovery & Development Why Keryx Shares SkyrocketedMotley Fool Wall Street Journal all 31 news articles » |
|
Insomnia concerns go unaddressed in heart failure patients
News-Medical.net The impact of insomnia on health and function is a major concern for patients with heart failure (HF), qualitative and quantitative research shows. “Our findings underscore the critical importance of evaluating sleep, including insomnia,” says the … |
Stage and grade dominate RCC outcomesNews-Medical.netTumor grade and American Joint Committee on Cancer stage have emerged as the most important predictors of mortality in a competing risks analysis of patients undergoing nephrectomy for renal cell car…
|
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime …
PharmiWeb.com (press release) Under the agreement ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately adding to ADC Therapeutics’ portfolio of proprietary ADC programs. |
WCHS-TV8Dancers Raise Awareness For Organ DonationWCHS-TV8An international group of dancers stopped in Institute to help bring awareness to the importance of organ donation. Step Afrika performed at West Virginia State University Monday evening. The gr…
|
ADC Therapeutics Licenses Proprietary Antibodies from Five Prime …
4-traders (press release) Under the agreement, ADC Therapeutics plans to initiate preclinical research and development of antibody-drug conjugates using the antibodies licensed from Five Prime immediately, adding to ADC Therapeutics’ portfolio of proprietary ADC programs. |
Vaccine News Daily |
Newly discovered monoclonal antibodies could control HIV
Vaccine News Daily A recently discovered group of monoclonal antibodies could serve as a new tool to control HIV, according to a study published on Wednesday in Nature. A team of scientists from the La Jolla, Calif.-based The Scripps Research Institute and other … AIDS antibodies fight infection in monkeysPrivate MD Theraclone Sciences’ Monoclonal Antibody Candidate PGT121 Suppresses HIV …EON: Enhanced Online News (press release) New experiment found suppressant for HIV-like virusSoutheast Missourian International Business Times AU all 6 news articles » |
Bioquark Inc. and International Expert on Brain Death, Dr. Calixto Machado, MD …Virtual-Strategy Magazine (press release)This initial exchange between Bioquark Inc., a novel development stage company focused on biological approaches to human regenera…